GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Holy Stone Healthcare Co Ltd (ROCO:4194) » Definitions » EBITDA Margin %

Holy Stone Healthcare Co (ROCO:4194) EBITDA Margin % : -113.56% (As of Jun. 2024)


View and export this data going back to 2013. Start your Free Trial

What is Holy Stone Healthcare Co EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Holy Stone Healthcare Co's EBITDA for the six months ended in Jun. 2024 was NT$-80.9 Mil. Holy Stone Healthcare Co's Revenue for the six months ended in Jun. 2024 was NT$71.3 Mil. Therefore, Holy Stone Healthcare Co's EBITDA margin for the quarter that ended in Jun. 2024 was -113.56%.


Holy Stone Healthcare Co EBITDA Margin % Historical Data

The historical data trend for Holy Stone Healthcare Co's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Holy Stone Healthcare Co EBITDA Margin % Chart

Holy Stone Healthcare Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -80.69 -48.31 -72.69 -47.50 -112.46

Holy Stone Healthcare Co Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -37.18 -59.55 -143.97 -94.55 -113.56

Competitive Comparison of Holy Stone Healthcare Co's EBITDA Margin %

For the Biotechnology subindustry, Holy Stone Healthcare Co's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Holy Stone Healthcare Co's EBITDA Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Holy Stone Healthcare Co's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Holy Stone Healthcare Co's EBITDA Margin % falls into.



Holy Stone Healthcare Co EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Holy Stone Healthcare Co's EBITDA Margin % for the fiscal year that ended in Dec. 2023 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=-266.415/236.89
=-112.46 %

Holy Stone Healthcare Co's EBITDA Margin % for the quarter that ended in Jun. 2024 is calculated as

EBITDA Margin %=EBITDA (Q: Jun. 2024 )/Revenue (Q: Jun. 2024 )
=-80.92/71.26
=-113.56 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Holy Stone Healthcare Co  (ROCO:4194) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Holy Stone Healthcare Co EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Holy Stone Healthcare Co's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Holy Stone Healthcare Co Business Description

Traded in Other Exchanges
N/A
Address
Number 88, Section 1, Neihu Road, 4th Floor, Neihu District, Taipei, TWN, 11493
Holy Stone Healthcare Co Ltd is a Taiwan based company focused on a biopolymer drug delivery platform. It is involved in the development of new drugs and medical devices, especially hyaluronic acid related therapeutic products. The products of the company include RenehaVis, SportVis, TRUD, and GAF.

Holy Stone Healthcare Co Headlines

No Headlines